Medical News

RSS

Researchers create device to find ways to improve commonly used treatment for 'water on the brain'

Van Andel Research Institute (VARI) scientists participated in a study with researchers from the University of Utah that could help find ways to improve shunt systems used to treat the neurological disorder hydrocephalus, or "water on the brain," the leading cause of brain surgery for children in the United States. Researchers studied the shunt systems under a variety of conditions by creating a bioreactor that mimics the environment inside patients.

24 Sep 2010

Navilyst Medical to distribute VasoNova's VPS central venous catheter navigation technology

VasoNova announced a strategic partnership with Navilyst Medical Inc. today to distribute its VasoNova™ Vascular Positioning System™ VPS™ central venous catheter navigation technology.

24 Sep 2010

Competition on access: A role for government in health care markets

In this Kaiser Health News column, Austin Frakt and Rexford Santerre write: "In late August, The Wall Street Journal reported that government-owned hospitals are 'drowning in debt' due to high health care costs, high rates of uninsured patients and cuts in public payments. Some government facilities are closing while others are being sold to private-sector firms.

24 Sep 2010

Cook Medical submits PMA to FDA for new balloon expandable stent for renal artery disease

Cook Medical has submitted its Pre-Market Approval (PMA) application to the U.S. Food and Drug Administration (FDA) for its new balloon expandable stent for renal artery disease. Intended for patients suffering from renal artery stenosis, a narrowing of the arteries that supply blood to the kidneys, the new device features a low profile design and does not shorten upon expansion.

24 Sep 2010

Hyland Software announces acquisition of Computer Systems Company

Hyland Software has purchased privately held Computer Systems Company, Inc. (dba The CSC Group), a provider of business and clinical healthcare software and document conversion services. Terms of the transaction were not disclosed.

24 Sep 2010

Mayo Clinic initiates enrollment in first U.S. clinical Hand Transplant Program

Mayo Clinic has initiated the first clinical Hand Transplant Program in the United States and is now enrolling patients. This program offers hand transplantation as a clinically available option for patients with bilateral hand injuries or amputations. This allows patients to embark on this option of reconstructive surgery without being required to enroll in experimental trials.

24 Sep 2010

Critics say school lunch bill could damage food stamp program

The New York Times: "In her campaign to reduce childhood obesity and improve school nutrition, Michelle Obama has become entangled in a fight with White House allies, including liberal Democrats and advocates for the poor." The bill, which the House is expected to consider in the next few days, "would come up with some of the money by cutting future food stamp benefits. When the Senate passed the bill in early August, Mrs. Obama said she was thrilled. But anti-hunger groups were not.

24 Sep 2010

Enobia announces positive results from ENB-0040 Phase II juvenile clinical trial for hypophosphatasia

Enobia Pharma today announced positive results for its Phase II juvenile clinical trial of ENB-0040 (asfotase alfa), an experimental bone-targeted enzyme replacement therapy intended for the treatment of hypophosphatasia (HPP). Hypophosphatasia is a rare, inherited, and sometimes fatal metabolic bone disease that affects individuals of all ages.

24 Sep 2010

Democratic pollster: White House needs to go 'back to basics' to sell health law

Kaiser Health News staff writer Jenny Gold spoke with Peter Hart, a Democratic pollster and chairman of Peter D. Hart Research Associates, who said he doesn't expect a sea change in public opinion in coming weeks and that Democrats might want to avoid discussing the health care law in their campaigns (Gold, 9/23).

24 Sep 2010

FDA grants ArthroCare marketing clearance for Parallax Contour Vertebral Augmentation Device

ArthroCare Corp., a leader in developing state-of-the-art, minimally invasive surgical products, announced today that it has received clearance from the U.S. Food and Drug Administration (FDA) to market its Parallax® Contour® Vertebral Augmentation Device (Contour) specifically for void creation in a vertebral body followed by injection of bone cement. Vertebral body void creation followed by bone cement augmentation is commonly used to treat painful vertebral compression fractures.

24 Sep 2010

Research Roundup: Medical homes; Drug samples and prescribing; The health law and disparities; Women's health; CBO projections

Institute of Medicine: Women's Health Research: Progress, Pitfalls, and Promise -"Substantial progress has been made since the expansion of investment in women's health research. Research findings have changed the practice of medicine and public-health recommendations in several prominent contexts, including changes in standards of care for women. There have also been decreases in mortality in women from breast cancer, heart disease, and cervical cancer. In other contexts, however, there has been less progress..."

24 Sep 2010

Political Cartoon: 'A nation divided'

Kaiser Health News provides a fresh perspective on health policy developments with "A Nation Divided" by John Rose.

24 Sep 2010

Amgen announces voluntary recall of certain lots of EPOGEN and PROCRIT

Amgen announced today that certain lots of EPOGEN® and PROCRIT® (Epoetin alfa) vials are being voluntarily recalled from specialty distributors, wholesalers, pharmacies and healthcare providers as a precaution. The product that is being recalled may contain extremely thin glass flakes (lamellae) that are barely visible in most cases. The lamellae result from the interaction of the formulation with glass vials over the shelf life of the product.

24 Sep 2010

Health law's 8 new changes – and 7 caveats

Kaiser Health News staff writer Mary Agnes Carey writes: "If you've tuned out the health care law you might want to tune back in. A set of new consumer protections goes into effect today, the six-month anniversary of the law. Here's a guide to some of the changes - and some of the caveats. Keep in mind that how they affect you will depend on what kind of insurance you have" (Carey, 9/23).

24 Sep 2010

25% of all Medicare beneficiaries enrolled in Medicare Advantage plans

As the annual open enrollment period approaches Medicare Advantage plan enrollment continues to inch upwards, with nearly 11.8 million people enrolled as of August 2010, almost 25% of all Medicare beneficiaries. Despite conservative growth strategies, stricter marketing regulations and legislation which reined in popular Private-Fee-For-Service plans, Medicare Advantage companies are still experiencing single digit growth rates, according to a new report by Mark Farrah Associates, a leading provider of market data and intelligence solutions.

24 Sep 2010

Perrigo files NDA with FDA for generic Zegerid OTC

Perrigo Company announced that it has filed with the U.S. Food and Drug Administration (FDA) an Abbreviated New Drug Application (ANDA) for omeprazole 20mg/sodium bicarbonate 1100mg, the generic equivalent of Zegerid OTC™, and that it provided prior notice of this filing to Schering-Plough HealthCare Products, Inc. a subsidiary of Merck & Co., Inc., the owner of the brand regulatory approval and the Curators of the University of Missouri, the listed patent owner.

24 Sep 2010

Results of Argos' Arcelis Phase 2 study for RCC accepted for presentation at International Kidney Cancer Symposium

Argos Therapeutics today announced that results from its Arcelis™ immunotherapy Phase 2 study for the treatment of renal cell carcinoma (RCC) have been accepted for a poster presentation at the Ninth International Kidney Cancer Symposium on Oct. 1-2 in Chicago.

24 Sep 2010

Gore completes enrollment in study of VIABAHN Endoprosthesis with Heparin Bioactive Surface

W. L. Gore & Associates (Gore) reported the complete enrollment in a post-market approval study designed to better characterize the performance of the GORE VIABAHN Endoprosthesis with Heparin Bioactive Surface in treating peripheral vascular disease (PVD) of the superficial femoral artery (SFA). The 11 participating sites enrolled a total of 120 patients in the Gore VIPER (GORE® VIABAHN® Endoprosthesis with Heparin Bioactive Surface for SuPERficial Femoral Artery Endoluminal Bypass) Study since initiation.

24 Sep 2010

Microfluidic Systems ranked #3035 on Inc. 5000

Microfluidic Systems, a privately-held company, announced today that they received an award from Inc. Magazine. The Fourth Annual Exclusive List of America's Fastest-Growing Private Companies—the Inc. 5000 ranked Microfluidic Systems number 3035 with a growth rate of 68%. The list represents the most comprehensive look at the most important segment of the economy—America's independent-minded entrepreneurs.

24 Sep 2010

Warner Chilcott subsidiaries to issue $500 million of 7-3/4% senior notes in private placement

Warner Chilcott plc today announced that its subsidiaries, Warner Chilcott Company, LLC and Warner Chilcott Finance LLC (together, the "Issuers"), plan to issue an aggregate principal amount of $500 million of 7-3/4% senior notes due 2018 (the "Notes") in a private placement. The notes are additional notes constituting a part of the same series as the $750 million aggregate principal amount of 7-3/4% senior notes due 2018 issued on August 20, 2010.

24 Sep 2010

Medical News

Researchers create device to find ways to improve commonly used treatment for 'water on the brain'

Navilyst Medical to distribute VasoNova's VPS central venous catheter navigation technology

Competition on access: A role for government in health care markets

Cook Medical submits PMA to FDA for new balloon expandable stent for renal artery disease

Hyland Software announces acquisition of Computer Systems Company

Mayo Clinic initiates enrollment in first U.S. clinical Hand Transplant Program

Critics say school lunch bill could damage food stamp program

Enobia announces positive results from ENB-0040 Phase II juvenile clinical trial for hypophosphatasia

Democratic pollster: White House needs to go 'back to basics' to sell health law

FDA grants ArthroCare marketing clearance for Parallax Contour Vertebral Augmentation Device

Research Roundup: Medical homes; Drug samples and prescribing; The health law and disparities; Women's health; CBO projections

Political Cartoon: 'A nation divided'

Amgen announces voluntary recall of certain lots of EPOGEN and PROCRIT

Health law's 8 new changes – and 7 caveats

25% of all Medicare beneficiaries enrolled in Medicare Advantage plans

Perrigo files NDA with FDA for generic Zegerid OTC

Results of Argos' Arcelis Phase 2 study for RCC accepted for presentation at International Kidney Cancer Symposium

Gore completes enrollment in study of VIABAHN Endoprosthesis with Heparin Bioactive Surface

Microfluidic Systems ranked #3035 on Inc. 5000

Warner Chilcott subsidiaries to issue $500 million of 7-3/4% senior notes in private placement

How real-time off-gas analysis improves fermentation process control

Advancing Drug Safety Assessment With AI, Predictive Modeling, and Human-Relevant Data

AI-powered analytics and experimental validation

Latest News